SOX2 and osteosarcoma: Consistently, osteosarcoma tumor cells growing on 7 kPa substrate showed lower sensitivity to doxorubicin (Dox) compared to 20 kPa and 55 kPa substrate with elevated levels of Sox2, Oct4 and Nanog [55].